Newsbenzinga
Jade Biosciences Says Phase 3 Start Of JADE101 In IgA Nephropathy Accelerated To Q4 2026; Phase 2 Interim Data Expected In Q2 2027
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…